Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
COMPOSITION FOR PREVENTING OR TREATING MOYAMOYA DISEASE
Document Type and Number:
WIPO Patent Application WO/2024/096707
Kind Code:
A1
Abstract:
The present invention relates to: a composition for preventing or treating Moyamoya disease, comprising, as an active ingredient, miRNAs or extracellular vesicles comprising same; and a composition for preventing or treating Moyamoya disease, comprising extracellular vesicles derived from a three-dimensional spheroid-type cell aggregate prepared by means of a novel preparation method. If miRNAs or extracellular vesicles comprising same, of the present invention, are used, the expression of miRNAs, which are downregulated in patients with Moyamoya disease or Moyamoya syndrome, is increased such that vascular anastomoses, an increase in cerebral blood vessel diameter, and an increase in cerebral blood flow can be induced. Therefore, miRNAs or extracellular vesicles comprising same, of the present invention, can be used as a novel therapeutic agent for treating Moyamoya disease or Moyamoya syndrome.

Inventors:
KIM EUN HEE (KR)
LEE WOO JOO (KR)
OH GYUN SIK (KR)
LEE NA EUN (KR)
Application Number:
PCT/KR2023/017597
Publication Date:
May 10, 2024
Filing Date:
November 03, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
S&E BIO CO LTD (KR)
International Classes:
A61K48/00; A61K31/7088; A61K35/28; A61P9/00; C12N5/0775
Foreign References:
KR20220061009A2022-05-12
CN110184338A2019-08-30
KR20170123852A2017-11-09
Other References:
MING-JEN LEE: "The Impact of Moyamoya Disease and RNF213 Mutations on the Spectrum of Plasma Protein and MicroRNA", JOURNAL OF CLINICAL MEDICINE, MULTIDISCIPLINARY DIGITAL PUBLISHING INSTITUTE (MDPI), CH, vol. 8, no. 10, CH , pages 1648, XP093169061, ISSN: 2077-0383, DOI: 10.3390/jcm8101648
GANG WANG: "A Panel of Exosome-Derived miRNAs of Cerebrospinal Fluid for the Diagnosis of Moyamoya Disease", FRONTIERS IN NEUROSCIENCE, FRONTIERS RESEARCH FOUNDATION, CH, vol. 14, CH , XP093169065, ISSN: 1662-453X, DOI: 10.3389/fnins.2020.548278
Attorney, Agent or Firm:
KAI INTERNATIONAL IP LAW FIRM (KR)
Download PDF: